HPLC and LC-MS: purity and identity evidence

A chromatogram and a mass spectrum describe different aspects of an analysis. Reading them together is often more useful than treating “HPLC” and “mass spec” as competing badges. The useful question is which claim each reported measurement supports.

What the separation and detector contribute

Liquid chromatography separates sample components under the conditions of a method. A detector records a response as material leaves the separation system. A UV chromatogram can support a method-specific purity assessment, but the word “HPLC” by itself does not describe the complete measurement.

In LC-MS, liquid chromatography is coupled to mass spectrometry. EMBL-EBI's training material explains that the mass spectrometer detects ions and records mass-to-charge information and signal intensity, with time information when coupled to chromatography. The chromatographic separation and the mass measurement therefore contribute different information within one workflow.

Retention time is supporting evidence

A peak appearing at an expected time can be useful, particularly alongside a suitable reference. It is not unique identification on its own: different compounds can have similar retention times. The University of Tartu's identity-confirmation course explains this limitation and the additional selectivity that spectrometric evidence can provide.

Ask which reference was used and how the sample and reference were compared. Keep the actual identity conclusion from the laboratory, rather than replacing it with a stronger claim inferred from a graph.

Read the mass-spectrum conclusion carefully

Look for the expected material, the measured ion or mass information, the instrument/method and the stated identification criteria. A full report should explain the connection between the observation and the identity conclusion. A screenshot with an unlabeled peak leaves that relationship unclear.

The University of Tartu's MS guidance discusses diagnostic ions and comparison with reference spectra recorded under comparable instrumental conditions. The specificity of the evidence matters; the mere presence of a mass-spectrum image is not a complete evaluation of identity.

Match the evidence to the claim

The ICH Q2(R2) analytical-validation guideline discusses selectivity, interference and supporting procedures when one procedure does not discriminate sufficiently. We cite those scientific principles here; this is not a claim that a PepBiotics material is a medicine or that its tests meet a regulatory submission standard.

For a research-material report, ask:

• Which result supports purity, and which supports identity?
• Were the methods applied to the same identified sample?
• What reference, acceptance criteria and limitations are documented?
• If quantity is claimed, where is the separate quantitative basis?

Use our purity versus content explanation for the last question, and the COA checklist to keep the results connected to their sample. None of these analytical records alone establishes suitability for human or veterinary use.